Protocol Ledger

NCT05958342 · Phase II · RECRUITING

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

Interventional Phase II clinical trial protocol NCT05958342 sponsored by Jason Sperry in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-06-30 Enrollment: 1,050 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05958342
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,050 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05958342
Protocol FieldVerified Registry Value
NCT IdentifierNCT05958342
Consolidated Lead SponsorJason Sperry
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment1,050 participants (ESTIMATED)
Registered Start Date2024-06-30
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI